Literature DB >> 2049250

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers.

D R Robertson1, I Higginson, B S Macklin, A G Renwick, D G Waller, C F George.   

Abstract

1. The pharmacokinetics of levodopa and paracetamol after single oral doses have been investigated in eight healthy young volunteers in the fasted state and following isocaloric meals containing either 10.5 g or 30.5 g of protein. 2. The initial peak and maximum plasma drug concentrations and the times at which these occurred were not affected by food. 3. The mean area under the plasma concentration-time curve (AUC) for paracetamol following an overnight fast did not differ significantly from that observed following the low and high protein meals. 4. By contrast, the AUC for levodopa following the low protein meal (193.9 +/- 15.7 micrograms ml-1 min) was significantly lower compared with administration in the fasted state (216.5 +/- 26.1 micrograms ml-1 min). However, there were no significant differences in the kinetics of levodopa between the fasting state and following the high protein meal. 5. There was no evidence that consumption of a meal containing 30.5 g of protein impaired either the rate or extent of absorption of levodopa. Therefore the reported beneficial effects of a low protein diet in the treatment of patients with Parkinson's disease probably result from reduced competition for levodopa transport across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049250      PMCID: PMC1368327          DOI: 10.1111/j.1365-2125.1991.tb05555.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Protein intake and treatment of Parkinson's disease with levodopa.

Authors:  I Mena; G C Cotzias
Journal:  N Engl J Med       Date:  1975-01-23       Impact factor: 91.245

2.  The influence of levodopa on gastric emptying in man.

Authors:  D R Robertson; A G Renwick; N D Wood; N Cross; B S Macklin; J S Fleming; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.

Authors:  K L Leenders; W H Poewe; A J Palmer; D P Brenton; R S Frackowiak
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

4.  Dietary influences on the antiparkinsonian response to levodopa.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; C Serrati; T N Chase
Journal:  Arch Neurol       Date:  1987-10

5.  Active transport of L-dopa in the intestine.

Authors:  D N Wade; P T Mearrick; J L Morris
Journal:  Nature       Date:  1973-04-13       Impact factor: 49.962

6.  Absorption and metabolism of L-dopa by the human stomach.

Authors:  L Rivera-Calimlim; C A Dujovne; J P Morgan; L Lasagna; J R Bianchine
Journal:  Eur J Clin Invest       Date:  1971-05       Impact factor: 4.686

Review 7.  The physiology and pathophysiology of gastric emptying in humans.

Authors:  H Minami; R W McCallum
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

8.  The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.

Authors:  J G Nutt; W R Woodward; J P Hammerstad; J H Carter; J L Anderson
Journal:  N Engl J Med       Date:  1984-02-23       Impact factor: 91.245

9.  "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy.

Authors:  C D Marsden; J D Parkes
Journal:  Lancet       Date:  1976-02-07       Impact factor: 79.321

10.  Plasma levels of amino acids correlate with motor fluctuations in parkinsonism.

Authors:  J H Pincus; K M Barry
Journal:  Arch Neurol       Date:  1987-10
View more
  11 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

3.  Gastric emptying in healthy volunteers after multiple doses of levodopa.

Authors:  D G Waller; C Roseveare; A G Renwick; B Macklin; C F George
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

4.  Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.

Authors:  Lixin Wang; Sachiko Mogami; Hiroshi Karasawa; Chihiro Yamada; Seiichi Yakabi; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  Peptides       Date:  2014-03-11       Impact factor: 3.750

5.  Levodopa availability improves with progression of Parkinson's disease.

Authors:  Dirk Woitalla; Oliver Goetze; Jeong I Kim; Alice B Nikodem; Wolfgang E Schmidt; Horst Przuntek; Thomas Müller
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

Review 6.  A Review of Food-Drug Interactions on Oral Drug Absorption.

Authors:  Jianyuan Deng; Xiao Zhu; Zongmeng Chen; Chun Ho Fan; Him Shek Kwan; Chi Ho Wong; Ka Yi Shek; Zhong Zuo; Tai Ning Lam
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

7.  The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum.

Authors:  D Nilsson; U Fagerholm; H Lennernäs
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

8.  The effect of L-leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.

Authors:  H Lennernäs; D Nilsson; S M Aquilonius; O Ahrenstedt; L Knutson; L K Paalzow
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 9.  Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.

Authors:  Aravind Mittur; Suneel Gupta; Nishit B Modi
Journal:  Clin Pharmacokinet       Date:  2017-09       Impact factor: 6.447

10.  Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients.

Authors:  Marouen Ben Guebila; Ines Thiele
Journal:  NPJ Syst Biol Appl       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.